{"log_id": 5389233689842078842, "direction": 0, "words_result_num": 47, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998282, "min": 0.994433}, "location": {"width": 487, "top": 80, "height": 50, "left": 359}, "words": "重组人粒细胞刺激因子注射液说明书"}, {"probability": {"variance": 2.1e-05, "average": 0.998034, "min": 0.980108}, "location": {"width": 341, "top": 132, "height": 36, "left": 416}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0, "average": 0.999722, "min": 0.999242}, "location": {"width": 112, "top": 180, "height": 28, "left": 199}, "words": "【药品名称】"}, {"probability": {"variance": 0.004973, "average": 0.978665, "min": 0.688478}, "location": {"width": 361, "top": 206, "height": 31, "left": 240}, "words": "通用名称;重组人粒细胞刺激因子注射液"}, {"probability": {"variance": 0.000763, "average": 0.987511, "min": 0.914654}, "location": {"width": 160, "top": 237, "height": 24, "left": 242}, "words": "商品名称:立生素"}, {"probability": {"variance": 0.003259, "average": 0.969818, "min": 0.786583}, "location": {"width": 462, "top": 261, "height": 24, "left": 241}, "words": "英文名称: Recombinant Human Granulocyte Colony-sti"}, {"probability": {"variance": 0.001683, "average": 0.954978, "min": 0.913953}, "location": {"width": 74, "top": 256, "height": 19, "left": 781}, "words": " Factor In"}, {"probability": {"variance": 0.000805, "average": 0.978092, "min": 0.924955}, "location": {"width": 432, "top": 288, "height": 26, "left": 241}, "words": "汉语拼音: Chongzu Ren Lixibao cijiyinzi Zhusheye"}, {"probability": {"variance": 2e-06, "average": 0.998398, "min": 0.996153}, "location": {"width": 112, "top": 315, "height": 26, "left": 197}, "words": "【成份】"}, {"probability": {"variance": 0.000472, "average": 0.992186, "min": 0.876369}, "location": {"width": 643, "top": 329, "height": 40, "left": 240}, "words": "本品主要成份为重组人粒细胞刺激因子,来源为基因工程重组的大肠杆菌"}, {"probability": {"variance": 5.7e-05, "average": 0.995698, "min": 0.973056}, "location": {"width": 262, "top": 367, "height": 26, "left": 240}, "words": "辅料:甘露醇、醋酸钠、醋酸"}, {"probability": {"variance": 0.000288, "average": 0.98961, "min": 0.960225}, "location": {"width": 114, "top": 392, "height": 26, "left": 194}, "words": "【性状】"}, {"probability": {"variance": 1e-06, "average": 0.999299, "min": 0.997012}, "location": {"width": 183, "top": 416, "height": 27, "left": 240}, "words": "本品为无色透明液体"}, {"probability": {"variance": 0, "average": 0.999652, "min": 0.99927}, "location": {"width": 113, "top": 444, "height": 26, "left": 195}, "words": "【适应症】"}, {"probability": {"variance": 0.000621, "average": 0.992375, "min": 0.883407}, "location": {"width": 759, "top": 457, "height": 39, "left": 238}, "words": "1.癌症化疗等原因导致中性粒细胞减少症:癌症患者使用骨髓抑制性化疗药物;特别"}, {"probability": {"variance": 2e-06, "average": 0.999352, "min": 0.993011}, "location": {"width": 802, "top": 483, "height": 40, "left": 198}, "words": "在强烈的骨髓剥夺性化学药物治疗后,注射本品有助于预防中性粒细胞减少症的发生,减"}, {"probability": {"variance": 6.3e-05, "average": 0.99606, "min": 0.95901}, "location": {"width": 799, "top": 506, "height": 42, "left": 198}, "words": "轻中性粒细胞减少的程度,缩短粒细胞缺乏症的持续时间,加速粒细胞数的恢复,从而减"}, {"probability": {"variance": 9e-06, "average": 0.997646, "min": 0.990159}, "location": {"width": 221, "top": 545, "height": 25, "left": 198}, "words": "少合并感染发热的危险性"}, {"probability": {"variance": 0.000234, "average": 0.994458, "min": 0.933166}, "location": {"width": 350, "top": 566, "height": 27, "left": 236}, "words": "2.促进骨髓移植后的中性粒细胞数升高"}, {"probability": {"variance": 0.000983, "average": 0.992991, "min": 0.807497}, "location": {"width": 760, "top": 580, "height": 43, "left": 237}, "words": "3.骨髓发育不良综合征引起的虫性粒细胞减少症,再生障碍性贫血引起的中性粒细胞"}, {"probability": {"variance": 0.001031, "average": 0.991058, "min": 0.815355}, "location": {"width": 789, "top": 607, "height": 43, "left": 197}, "words": "减少症,先天性、特发性中性粒细胞减少症,骨髓增生异常综合征伴中性粒细胞减少症"}, {"probability": {"variance": 0.037739, "average": 0.904466, "min": 0.420643}, "location": {"width": 367, "top": 636, "height": 36, "left": 195}, "words": "周期性中性粒细胞减少症人商"}, {"probability": {"variance": 0.000227, "average": 0.990284, "min": 0.964254}, "location": {"width": 111, "top": 675, "height": 24, "left": 193}, "words": "【规格】"}, {"probability": {"variance": 0.036897, "average": 0.825672, "min": 0.391641}, "location": {"width": 603, "top": 688, "height": 37, "left": 237}, "words": "7g/瓶、100g/瓶、15OHg瓶200g瓶、25Og1瓶、300g8瓶"}, {"probability": {"variance": 6.3e-05, "average": 0.993242, "min": 0.981577}, "location": {"width": 112, "top": 725, "height": 24, "left": 191}, "words": "【用法用量】"}, {"probability": {"variance": 0.001104, "average": 0.987475, "min": 0.824273}, "location": {"width": 760, "top": 732, "height": 45, "left": 235}, "words": "化疗药物给药结束后24~48小时起皮不静脉注射本品,每日一次。本品的用量和"}, {"probability": {"variance": 0.006613, "average": 0.980003, "min": 0.500211}, "location": {"width": 800, "top": 757, "height": 47, "left": 193}, "words": "用药时间应根据患者化疗的强度和申性粒细胞下降的程度决定。对化疗强度较大或粒细胞"}, {"probability": {"variance": 0.003637, "average": 0.9813, "min": 0.618003}, "location": {"width": 788, "top": 784, "height": 44, "left": 197}, "words": "下降较明显的患者以2.5gkg体重日的剂量(1~2支)连续用药7天以上较为适宜"}, {"probability": {"variance": 0.006137, "average": 0.971282, "min": 0.608157}, "location": {"width": 802, "top": 810, "height": 45, "left": 193}, "words": "至中性粒细胞恢复至5000/m3停药;如所用化疗药物的剂量较低,估计所造成的骨髓抑制"}, {"probability": {"variance": 0.003298, "average": 0.98525, "min": 0.623891}, "location": {"width": 802, "top": 832, "height": 48, "left": 194}, "words": "不太严重者,可考虑使用较低剂量预防中性粒细胞减少,以1.25g/kg体重/日的剂量用"}, {"probability": {"variance": 0.035299, "average": 0.832984, "min": 0.398148}, "location": {"width": 779, "top": 842, "height": 177, "left": 253}, "words": "肌肉骨系统:有时会有肌肉酸痛骨痛痛、胸痛的现"}, {"probability": {"variance": 0.000595, "average": 0.993025, "min": 0.857893}, "location": {"width": 677, "top": 862, "height": 44, "left": 191}, "words": "药至中性粒细胞数稳定于安全范围;对化疗后中性粒细胞已明显降低的患者"}, {"probability": {"variance": 0.011067, "average": 0.958174, "min": 0.36957}, "location": {"width": 658, "top": 887, "height": 44, "left": 196}, "words": "<1000/m3),以5g/kg体重/口的剂量(12支)用药至中性粒细胞恢复至"}, {"probability": {"variance": 1e-06, "average": 0.999177, "min": 0.996243}, "location": {"width": 285, "top": 923, "height": 32, "left": 191}, "words": "稳定后终止本品治疗并监视病情"}, {"probability": {"variance": 0.014732, "average": 0.926484, "min": 0.628593}, "location": {"width": 784, "top": 1009, "height": 43, "left": 229}, "words": "3其他有会出现发热、头疼、乏力及疹,AP、LDH升高"}, {"probability": {"variance": 0.012232, "average": 0.971913, "min": 0.368889}, "location": {"width": 676, "top": 1035, "height": 50, "left": 227}, "words": "4极少数人会出现休克、间质性肺炎、成人呼吸窘迫综合征、幼私细胞增加"}, {"probability": {"variance": 0.008785, "average": 0.963089, "min": 0.563287}, "location": {"width": 746, "top": 1064, "height": 70, "left": 227}, "words": "1.对粒细胞刺激因子过敏者以及对大肠杆菌表达的其他制剂过敏者禁用:06002923"}, {"probability": {"variance": 4e-06, "average": 0.998792, "min": 0.995358}, "location": {"width": 113, "top": 1082, "height": 24, "left": 186}, "words": "【禁忌】"}, {"probability": {"variance": 0.000122, "average": 0.995162, "min": 0.953494}, "location": {"width": 355, "top": 1119, "height": 40, "left": 225}, "words": "2.严重肝、肾、心、肺功能障碍者禁用"}, {"probability": {"variance": 9e-06, "average": 0.998771, "min": 0.981343}, "location": {"width": 764, "top": 1136, "height": 48, "left": 227}, "words": "3.骨髓中幼稚粒细胞未显著减少的骨髓性白血病患者或外周血中检出幼稚粒细胞的骨"}, {"probability": {"variance": 1e-06, "average": 0.998015, "min": 0.996178}, "location": {"width": 148, "top": 1181, "height": 30, "left": 186}, "words": "髓性白血病患者"}, {"probability": {"variance": 0, "average": 0.999553, "min": 0.998669}, "location": {"width": 107, "top": 1208, "height": 30, "left": 186}, "words": "【注意事项】"}, {"probability": {"variance": 0.001279, "average": 0.988894, "min": 0.818097}, "location": {"width": 496, "top": 1220, "height": 42, "left": 224}, "words": "1.本品应在化疗药物给药结束后24~48小时开始使用"}, {"probability": {"variance": 0.001728, "average": 0.98888, "min": 0.749631}, "location": {"width": 721, "top": 1239, "height": 48, "left": 223}, "words": "2.使用本品过程中应定期每周监测血象2次,特别是中性粒细胞数目变化的情况"}, {"probability": {"variance": 0.013494, "average": 0.964942, "min": 0.441309}, "location": {"width": 658, "top": 1267, "height": 45, "left": 222}, "words": "3.对髓性细胞系统的恶性增殖(急性粒细胞性白血病等)本品应慎重使用"}, {"probability": {"variance": 0.009808, "average": 0.973262, "min": 0.502187}, "location": {"width": 575, "top": 1295, "height": 43, "left": 224}, "words": "4.长期使用本品的安全有效性尚未建立,曾有报导可见脾脏增大"}, {"probability": {"variance": 0.00407, "average": 0.981774, "min": 0.679518}, "location": {"width": 765, "top": 1314, "height": 51, "left": 224}, "words": "虽然本品临床试验未发生过敏反应病例,但国外同类制剂曾发生少数过敏反应(发生"}], "language": 3}